Evidence map›Paper›PMID 36505015›Full record

ReviewThe Pan African medical journal2022

Cervical cancer screening in women living with HIV attending primary care clinics in a health district, South Africa: a descriptive cross-sectional study.

Mmipe Lillian Saasa-Modise, John Mukuka Musonda, Joyce Sikwese-Musonda, Nomvula Josephine Maseko, Lineo Hlophe, Griffiths Kubeka

Open access · goldAbstract readReview
In one paragraph

Review in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Knowledge translation and integration of research evidence into practice: A national mandate.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mmipe Lillian Saasa-ModiseDepartment of Family Medicine and Primary Health Care, University of Witwatersrand, Johannesburg, South Africa.
John Mukuka MusondaDepartment of Family Medicine and Primary Health Care, University of Witwatersrand, Johannesburg, South Africa.
Joyce Sikwese-MusondaDepartment of Family Medicine and Primary Health Care, University of Pretoria, Pretoria, South Africa.
Nomvula Josephine MasekoDistrict Clinical Specialist Team, Ekurhuleni Health District, Germiston, South Africa.
Lineo HlopheDistrict Clinical Specialist Team, Ekurhuleni Health District, Germiston, South Africa.
Griffiths KubekaAurum Institute, Johannesburg, South Africa.
University of the Witwatersrand · ZAUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: globally, cervical cancer remains a public health problem. It is ranked the fourth most common cause of women's cancer. In South Africa, it was the second most common cancer diagnosed in 2012. The disease progresses rapidly in women living with Human Immunodeficiency Virus (HIV), due to immune suppression. The purpose was to evaluate cervical cancer screening in HIV-positive women attending primary health care (PHC) clinics in Ekurhuleni Health District (EHD), South Africa. Aim and Objectives: the study aim was to evaluate cervical cancer screening in HIV-positive women attending PHC clinics for routine care in Ekurhuleni Health District, Gauteng Province, South Africa. Objectives were to describe the cervical cancer screening uptake of HIV-positive women on antiretroviral therapy (ART) who remained in care and were screened, determine the length of time or period from starting ART to the first cervical cancer screening, and describe associations among screening, age, and the period from starting ART. Methods: this was a retrospective descriptive cross-sectional study design. A review of clinic records was conducted on women living with HIV and on antiretroviral therapy for at least four years. The study period was from March to September 2020. After a clustered randomization of clinics, 550 records were systematically selected. Stata version 16.1 was used for analysis. Results: the median age was 34, ranged 23-68, with the interquartile range (IQR) of 29-42 years. Nearly a third (32.9%, n= 181) had cervical cancer screening documented. Those with both an ART start date and first screening were 83% (n= 151). The median for ART duration was 5 years and ranged from 4-8 years. The median time to first screening was 43 weeks with an IQR of 16-67 weeks. Women aged 35-44 years or above 45 were more likely to be screened (AOR 3.2, CI: 1.0-9.8, p= 0.05) and (AOR 5.3, CI: 1.7-16.9, p= 0.01), respectively. Conclusion: there was suboptimal uptake and delay in initiating screening in women living with HIV. Nevertheless, the older women were, more likely to be screened. This study suggests poor adherence to policy and highlights the need for accelerated staff training on cervical cancer policy.

Indexed as

HIV SeropositivityUterine Cervical NeoplasmsAdultAgedCross-Sectional StudiesEarly Detection of CancerFemaleHIVHumansMiddle AgedPrimary Health CareRetrospective StudiesSouth AfricaYoung Adultantiretroviral therapyCervical cancer screeninghuman immunodeficiency virusSouth Africauptake

Identifiers

PMID36505015
PMCPMC9716964
OpenAlexW4296503531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.